(HLXB) Helix Acquisition II - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock •
HLXB: Merger, Acquisition, Business, Combination
Helix Acquisition Corp. II Class A Ordinary Shares (NASDAQ:HLXB) is a blank-check company formed to execute a merger, asset acquisition, or other business combination. Incorporated in 2021 and headquartered in Boston, Massachusetts, the firm operates as a Special Purpose Acquisition Company (SPAC), focusing on identifying and acquiring a target company with strong growth potential. The companys structure allows it to pursue opportunities across various industries, leveraging its management teams expertise to create shareholder value.
HLXB shares are listed on the NASDAQ exchange under the ticker symbol HLXB. The stock is classified as common equity, representing ownership in the company. As a SPAC, HLXBs primary objective is to complete a business combination within a specified timeframe, typically 18-24 months from its initial public offering (IPO). The firms sponsors and management team play a critical role in sourcing and negotiating potential targets, often focusing on sectors with high growth prospects such as technology, healthcare, or renewable energy.
Based on the provided data, HLXB shares are currently trading at $11.05, with a 20-day average volume of 47,738. The stocks short-term momentum, as indicated by its SMA 20 and SMA 50, suggests a bullish trend, with prices rising above the 20-day moving average of $10.75 and the 50-day moving average of $10.72. The 200-day moving average of $10.46 further confirms the stocks upward trajectory. The Average True Range (ATR) of 0.14 indicates relatively low volatility, making the stock less risky for short-term traders.
From a fundamental perspective, HLIXB has a market capitalization of $251.55 million, reflecting its size as a small-cap company. The price-to-book (P/B) ratio of 1.35 suggests that investors are valuing the stock slightly above its book value, which is common for SPACs in the pre-merger phase. The return on equity (RoE) of 3.00% indicates modest profitability, likely driven by interest income from the trust account holding the proceeds from its IPO.
3-Month Forecast
Over the next three months, HLXB is expected to maintain its bullish momentum, supported by its position above key moving averages. The stock is likely to trade in a range of $10.50 to $11.50, with potential upside driven by positive developments in its merger negotiations. The low ATR of 0.14 suggests that volatility will remain manageable, making the stock attractive for risk-averse investors seeking exposure to the SPAC market. Fundamentally, the companys ability to announce a high-quality target will be a key driver of shareholder value during this period.
Additional Sources for HLXB Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
HLXB Stock Overview
| Market Cap in USD | 255m |
| Sector | Financial Services |
| Industry | Shell Companies |
| GiC Sub-Industry | Multi-Sector Holdings |
| IPO / Inception | 2024-02-09 |
HLXB Stock Ratings
| Growth 5y | 44.0% |
| Fundamental | -26.6% |
| Dividend | 0.0% |
| Rel. Strength Industry | -13 |
| Analysts | - |
| Fair Price Momentum | 10.07 USD |
| Fair Price DCF | - |
HLXB Dividends
No Dividends PaidHLXB Growth Ratios
| Growth Correlation 3m | 35.9% |
| Growth Correlation 12m | 85.5% |
| Growth Correlation 5y | 76.9% |
| CAGR 5y | 6.47% |
| CAGR/Max DD 5y | 1.39 |
| Sharpe Ratio 12m | -0.33 |
| Alpha | -0.24 |
| Beta | -0.07 |
| Volatility | 17.25% |
| Current Volume | 6.8k |
| Average Volume 20d | 1.7k |
As of March 11, 2025, the stock is trading at USD 10.70 with a total of 6,800 shares traded.
Over the past week, the price has changed by -1.74%, over one month by -0.93%, over three months by +1.42% and over the past year by +4.29%.
Probably not. Based on ValueRay Fundamental Analyses, Helix Acquisition II (NASDAQ:HLXB) is currently (March 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -26.55 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HLXB as of March 2025 is 10.07. This means that HLXB is currently overvalued and has a potential downside of -5.89%.
Helix Acquisition II has no consensus analysts rating.
According to ValueRays Forecast Model, HLXB Helix Acquisition II will be worth about 10.9 in March 2026. The stock is currently trading at 10.70. This means that the stock has a potential upside of +1.68%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 10.9 | 1.7% |